{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:15:10Z","timestamp":1788520510358,"version":"build-2803163510"},"reference-count":12,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,8,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To identify the factors influencing outcome in childhood mature B-cell non-Hodgkin lymphoma and acute leukemia (B-NHL\/AL) with central nervous system (CNS) disease (CNS+), we analyzed patients &amp;lt;18 years with newly diagnosed B-NHL\/AL registered in 3 Lymphomes Malins B studies in France between 1989 to 2011. CNS+ was diagnosed on fulfillment of \u22651 of the following criteria: any L3 cerebrospinal fluid (CSF) blasts (CSF+), cranial nerve palsy, isolated intracerebral mass but also clinical spinal cord compression, and cranial or spinal parameningeal extension. Two hundred seventeen out of 1690 patients (12.8%) were CNS+. CNS+ was significantly associated with male gender, head\/neck locations, Burkitt histology, high initial lactate dehydrogenase (LDH) level, and bone marrow involvement. CSF+ was the most frequent pattern of CNS+ (45%). For the 217 CNS+ patients, the 5-year event-free survival (EFS) and overall survival rates (95% confidence interval) were 81.5% (75.8% to 86.1%) and 83.9% (78.4% to 88.2%), respectively. In multivariate analysis, among CNS+ patients, low EFS was associated with CSF+, high initial LDH level, and poor response to cyclophosphamide, oncovin (vincristine), prednisone prephase. These findings have been considered for patient\u2019s stratification in the international randomized phase 3 trial Inter-B-NHL-ritux 2010 for children and adolescents with high-risk B-NHL\/AL with CNS+ CSF+ patients only receiving intensified chemotherapy.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019001398","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T16:36:20Z","timestamp":1596818180000},"page":"3621-3625","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["In childhood mature B-NHL with CNS disease, patients with blasts in cerebrospinal fluid are at higher risk of failure"],"prefix":"10.1182","volume":"4","author":[{"given":"Mathieu","family":"Simonin","sequence":"first","affiliation":[{"name":"Department of Pediatric Oncology and Hematology, Armand Trousseau Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris and Sorbonne University, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Auperin","sequence":"additional","affiliation":[{"name":"Unit of Biostatistics and Epidemiology, Gustave Roussy, Paris-Saclay University, INSERM 1018, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Bertrand","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology, Institute of Pediatric Hematology and Oncology, Claude Bernard University Lyon, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Aladjidi","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and Haematology, University Hospital of Bordeaux, Bordeaux, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Baruchel","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Immunology, Robert Debr\u00e9 Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris and University Paris Diderot, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Contet","sequence":"additional","affiliation":[{"name":"Department of Pediatric Onco-Hematology, University Hospital of Nancy, Nancy, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3996-3835","authenticated-orcid":false,"given":"Carole","family":"Coze","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Timone Enfants Hospital, Assistance Publique\u2013H\u00f4pitaux de Marseille and Aix-Marseille University, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Gandemer","sequence":"additional","affiliation":[{"name":"Department of Pediatric Onco-Hematology, University Hospital of Rennes, University of Rennes 1, Rennes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Haouy","sequence":"additional","affiliation":[{"name":"Department of Pediatric Onco-Hematology, University Hospital of Montpellier, Montpellier, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Leblanc","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Immunology, Robert Debr\u00e9 Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris and University Paris Diderot, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Leverger","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and Hematology, Armand Trousseau Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris and Sorbonne University, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Michon","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, SIREDO, Institut Curie, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Patte","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Oncology, Gustave Roussy, Paris-Saclay University, Villejuif, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0296-5207","authenticated-orcid":false,"given":"Veronique","family":"Minard-Colin","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Oncology, Gustave Roussy, Paris-Saclay University, Villejuif, France; and"},{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"issue":"25","key":"2020080711343008300_B1","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1200\/JCO.2007.11.0700","article-title":"Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin\u2019s lymphoma differ by non-Hodgkin\u2019s lymphoma subtype: a Berlin-Frankfurt-Munster Group Report","volume":"25","author":"Salzburg","year":"2007","journal-title":"J Clin Oncol"},{"issue":"16","key":"2020080711343008300_B2","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1200\/JCO.2000.18.16.3018","article-title":"CNS involvement in children with newly diagnosed non-Hodgkin\u2019s lymphoma","volume":"18","author":"Sandlund","year":"2000","journal-title":"J Clin Oncol"},{"issue":"4","key":"2020080711343008300_B3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1200\/JCO.2010.33.3369","article-title":"Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (\u2265 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin\u2019s lymphoma: results of the FAB LMB 96 study","volume":"30","author":"Cairo","year":"2012","journal-title":"J Clin Oncol"},{"issue":"10","key":"2020080711343008300_B4","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2000.18.10.2017","article-title":"Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children\u2019s Cancer Group study","volume":"18","author":"Gururangan","year":"2000","journal-title":"J Clin Oncol"},{"issue":"7","key":"2020080711343008300_B5","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","article-title":"Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents","volume":"109","author":"Cairo","year":"2007","journal-title":"Blood"},{"issue":"18","key":"2020080711343008300_B6","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1200\/JCO.2014.59.7203","article-title":"Revised International Pediatric Non-Hodgkin Lymphoma Staging System","volume":"33","author":"Rosolen","year":"2015","journal-title":"J Clin Oncol"},{"issue":"3","key":"2020080711343008300_B7","first-page":"332","article-title":"Classification, staging and end results of treatment of childhood non-Hodgkin\u2019s lymphomas: dissimilarities from lymphomas in adults","volume":"7","author":"Murphy","year":"1980","journal-title":"Semin Oncol"},{"issue":"11","key":"2020080711343008300_B8","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","article-title":"The Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Oncologie P\u00e9diatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"},{"issue":"282","key":"2020080711343008300_B9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"8","key":"2020080711343008300_B10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0021-9681(78)90043-7","article-title":"Estimation of confidence limits for the cumulative probability of survival in life table analysis","volume":"31","author":"Rothman","year":"1978","journal-title":"J Chronic Dis"},{"issue":"1","key":"2020080711343008300_B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples","volume":"35","author":"Peto","year":"1977","journal-title":"Br J Cancer"},{"issue":"2","key":"2020080711343008300_B12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/15\/3621\/1752239\/advancesadv2019001398.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/15\/3621\/1752239\/advancesadv2019001398.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T13:35:31Z","timestamp":1723383331000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/15\/3621\/461712\/In-childhood-mature-BNHL-with-CNS-disease-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":12,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2020,8,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019001398","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,7]]}}}